* Cardlytics Inc CDLX.OQ CDLX.O is expected to show a
fall in
quarterly revenue when it reports results on March 1.
* The Atlanta Georgia-based company is expected to report
a
7.2% decrease in revenue to $83.543 million from $90.05 million
a year ago, according to the mean estimate from 6 analysts,
based on Refinitiv data. The company's guidance on November 1
2022, for the period ended December 31, was for revenue between
$80.00 million and $90.00 million.
* Refinitiv's mean analyst estimate for Cardlytics Inc is
for a
loss of 46 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cardlytics
Inc is
$7, above its last closing price of $5.56.
The company's guidance on November 1 2022 for the period ended
December 31 was for Earnings before Interest, Taxes,
Depreciation and Amortization of between 80 million and -2
million (USD).
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 -0.50 -0.57 -0.50 Beat 12.3
Jun. 30 2022 -0.42 -0.47 -0.65 Missed -38.9
Mar. 31 2022 -0.52 -0.55 -0.38 Beat 31.3
Dec. 31 2021 -0.36 -0.42 -0.15 Beat 63.9
Sep. -0.52 -0.54 -0.33 Beat 38.9
30 2021
Jun. 30 2021 -0.38 -0.39 -0.39 Met -0.9
Mar. 31 2021 -0.44 -0.34 -0.34 Met -0.6
Dec. 31 2020 -0.04 -0.03 -0.05 Missed -92.3
This summary was machine generated February 28 at 01:43 GMT.
All figures in US dollars unless otherwise stated